A Phase I Study to Assess the Safety and Immunogenicity of Novel Schedules for Vaccination With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2015
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary)
- Indications Malaria
- Focus Adverse reactions
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2012 Planned end date changed from 25 Jul 2013 to 14 Aug 2012 as reported by United Kingdom Clinical Research Network record.
- 22 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.